Clearmind Medicine (CMND) - 2023 Q1 - Quarterly Report

Exhibit 99.1 CLEARMIND MEDICINE INC. Condensed Interim Consolidated Financial Statements For The Three Months Ended January 31, 2023 (Expressed in Canadian Dollars) (Unaudited) CLEARMIND MEDICINE INC. Condensed Interim Consolidated Statements of Financial Position (Expressed in Canadian Dollars) (Unaudited) January 31, October 31, 2023 2022 Assets Current assets Cash and cash equivalents 4,498,0484,498,048 175,768 Other receivables 291,829 69,518 Short-term investment (Note 3) 180,225 264,449 Prepaid expenses 93 ...